Product Information
AUVI-Q 0.3 MG AUTO-INJECTOR is a brand product labeled by kaleo, Inc, priced at $309.3757 per EA under NDC 60842002302. Its NADAC has been published 102 times since Sep 11, 2024.
FDA first approved this application on Aug 10, 2012. Its Orange Book therapeutic-equivalence code is BX.
Strength
.3 mg/.3mL
Manufacturer
kaleo, IncNDC
60842002302
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
7/1/2026
Active Ingredients
EPINEPHRINEApproval Type
New Drug (NDA)
FDA Application
NDA201739FDA Approved
8/10/2012
TE Code
BX
On Market Since
11/15/2012
Pharmacological Classes
Price Statistics
The NADAC for AUVI-Q 0.3 MG AUTO-INJECTOR has been published 102 times since Sep 11, 2024, and over the history we have for it it has risen 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $309.3757 per EA |
|---|---|
| All-time high | $309.3757 (Aug 19, 2026) |
| All-time low | $297.4131 (Dec 17, 2025) |
| 52-week high | $309.3757 |
| 52-week low | $297.4131 |
| Median price | $298.0317 |
| Average price | $298.6617 |
| Largest weekly change | +4.0% (Jul 8, 2026) |
| Weeks tracked | 102 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AUVI-Q 0.3 MG AUTO-INJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for AUVI-Q 0.3 MG AUTO-INJECTOR, manufactured by kaleo, Inc, is $309.3757 per EA (NDC 60842002302), effective Aug 19, 2026.
How has the price of AUVI-Q 0.3 MG AUTO-INJECTOR changed over time?
Over the history we have for it, the NADAC for AUVI-Q 0.3 MG AUTO-INJECTOR has risen 3.7%. It has been tracked across 102 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for AUVI-Q 0.3 MG AUTO-INJECTOR?
Since Sep 11, 2024, the NADAC for AUVI-Q 0.3 MG AUTO-INJECTOR has ranged from a low of $297.4131 (Dec 17, 2025) to a high of $309.3757 (Aug 19, 2026), with a median of $298.0317 per EA.
Are there cheaper alternatives to AUVI-Q 0.3 MG AUTO-INJECTOR?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPINEPHRINE 0.3 MG AUTO-INJECT, is $112.9870 per EA — about 63% below AUVI-Q 0.3 MG AUTO-INJECTOR.
Who manufactures AUVI-Q 0.3 MG AUTO-INJECTOR?
AUVI-Q 0.3 MG AUTO-INJECTOR (NDC 60842002302) is labeled by kaleo, Inc, and CMS classifies it as a brand product.